Search





Search





Markets
/
Stocks
/
nyxh
/

Nyxoah SA

NYXH

Add to Watchlist

1.400USD

-0.010-0.71%

Close 07-31 16:00（ET）Quotes delayed by 15 min

60.24MMarket Cap

LossP/E TTM

Nyxoah SA

1.400

-0.010-0.71%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-0.71%

5 Days

0.00%

1 Month

-21.35%

6 Months

-70.53%

Year to Date

-69.57%

1 Year

-80.82%

Key Figures

1.395Open

1.405High

332.69KVolume

LossP/E TTM

LossP/E Dynamic

--Dividend TTM

0.77%Turnover Ratio

1.410Prev. Close

1.350Low

370.87KTurnover

LossP/E Static

1.06P/B

0.00%Div Yield TTM

-71.64%ROA

8.87052wk High

2.55Volume Ratio

-59.24MNet Profit

43.03MShares

-1.8480EPS TTM

0.98Beta

-129.97%ROE

2.30052wk Low

3.90%Amplitude

57.09%Gross Margin

60.24MMarket Cap

-5.43Reward/Risk

3.75%Risk Rate

TradingKey Stock Score of Nyxoah SA

Currency: USD Updated: 2026-07-31

Key Insights

Nyxoah SA's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 84 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nyxoah SA's Score

Industry at a Glance

Industry Ranking

84 / 199

Overall Ranking

171 / 4281

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Nyxoah SA Highlights

StrengthsRisks

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 189.88% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 11.61M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 11.61M.

Overvalued

The company’s latest PE is -0.76, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 9.38M shares, decreasing 8.08% quarter-over-quarter.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.74.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

8.500

Target Price

+511.51%

Upside Space

Nyxoah SA News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 5 analysts

Buy

Current Rating

8.500

Target Price

+511.51%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Nyxoah SA

NYXH

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Indicators

Indicators

Sell(1)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.012

Neutral

RSI(14)

31.724

Neutral

STOCH(KDJ)(9,3,3)

16.579

Neutral

ATR(14)

0.068

Low Volatility

CCI(14)

-90.597

Neutral

Williams %R

84.375

Oversold

TRIX(12,20)

-0.918

Sell

StochRSI(14)

84.425

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.406

Sell

MA10

1.453

Sell

MA20

1.552

Sell

MA50

1.849

Sell

MA100

2.485

Sell

MA200

3.663

Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Nyxoah SA Info

Ticker SymbolNYXH

CompanyNyxoah SA

CEOTaelman (Olivier)

Websitehttps://www.nyxoah.com/

Shareholders

Shareholders

Proportion

Cochlear Limited

13.39%

Taub (Robert)

9.87%

Monden (Anneliese)

6.73%

Gilde Healthcare Partners B.V.

6.73%

ResMed Inc

3.96%

Other

59.32%

Popular Instruments

FAQs

What is the current price of Nyxoah SA (NYXH)?



The current price of Nyxoah SA (NYXH) is 1.40.

What is the symbol of Nyxoah SA?



The ticker symbol of Nyxoah SA is NYXH.

What is the 52-week high of Nyxoah SA?



The 52-week high of Nyxoah SA is 8.87.

What is the 52-week low of Nyxoah SA?



The 52-week low of Nyxoah SA is 2.30.

What is the market capitalization of Nyxoah SA?



The market capitalization of Nyxoah SA is 60.24M.

Is Nyxoah SA (NYXH) currently rated as Buy, Hold, or Sell?



According to analysts, Nyxoah SA (NYXH) has an overall rating of Buy, with a price target of 8.50.

What is the Earnings Per Share (EPS TTM) of Nyxoah SA (NYXH)?



The Earnings Per Share (EPS TTM) of Nyxoah SA (NYXH) is -2.78.